Literature DB >> 29193104

Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia.

Mouna Ouchari1, Kshitij Srivastava1, Houda Romdhane2, Saloua Jemni Yacoub2, Willy Albert Flegel1.   

Abstract

BACKGROUND: With more than 460 RHD alleles, this gene is the most complex and polymorphic among all blood group systems. The Tunisian population has the largest known prevalence of weak D Type 4.0 alleles, occurring in one of 105 RH haplotypes. We aimed to establish a rationale for the transfusion strategy of weak D Type 4.0 in Tunisia. STUDY DESIGN AND METHODS: Donors were randomly screened for the serologic weak D phenotype. The RHD coding sequence and parts of the introns were sequenced. To establish the RH haplotype, the RHCE gene was tested for characteristic single-nucleotide positions.
RESULTS: We determined all RHD alleles and the RH haplotypes coding for the serologic weak D phenotype among 13,431 Tunisian donations. A serologic weak D phenotype was found in 67 individuals (0.50%). Among them, 60 carried a weak D Type 4 allele: 53 weak D Type 4.0, six weak D Type 4.2.2 (DAR), and one weak D Type 4.1. An additional four donors had one variant allele each: DVII, weak D Type 1, weak D Type 3, and weak D type 100, while three donors showed a normal RHD sequence. The weak D Type 4.0 was most often linked to RHCE*ceVS.04.01, weak D Type 4.2.2 to RHCE*ceAR, and weak D Type 4.1 to RHCE*ceVS.02, while the other RHD alleles were linked to one of the common RHCE alleles.
CONCLUSIONS: Among the weak D phenotypes in Tunisia, no novel RHD allele was found and almost 90% were caused by alleles of the weak D Type 4 cluster, of which 88% represented the weak D Type 4.0 allele. Based on established RH haplotypes for variant RHD and RHCE alleles and the lack of adverse clinical reports, we recommend D+ transfusions for patients with weak D Type 4.0 in Tunisia.
© 2017 AABB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29193104      PMCID: PMC5803429          DOI: 10.1111/trf.14411

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  50 in total

1.  Weak D alleles express distinct phenotypes.

Authors:  F F Wagner; A Frohmajer; B Ladewig; N I Eicher; C B Lonicer; T H Müller; M H Siegel; W A Flegel
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

2.  RHD zygosity assignments based on most probable genotype and hybrid Rhesus box detection in Tunisia.

Authors:  Narjes Kacem; Tahar Chakroun; Hajer Moussa; Saïda Abdelkefi; Betoul Houissa; Jacques Chiaroni; Saloua Jemni Yacoub
Journal:  Transfus Med       Date:  2012-07-04       Impact factor: 2.019

3.  Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.

Authors:  Kevin J Pirelli; Bradley C Pietz; Susan T Johnson; Holly L Pinder; Daniel B Bellissimo
Journal:  Prenat Diagn       Date:  2010-12       Impact factor: 3.050

4.  Outliers in RhD membrane integration are explained by variant RH haplotypes.

Authors:  Xinjian Yu; Franz F Wagner; Bernd Witter; Willy A Flegel
Journal:  Transfusion       Date:  2006-08       Impact factor: 3.157

5.  RHD*weak partial 4.0 is associated with an altered RHCE*ce(48C, 105T, 733G, 744C, 1025T) allele in the Tunisian population.

Authors:  M Ouchari; H Polin; H Romdhane; S Abdelkefi; B Houissa; T Chakroun; C Gabriel; S Hmida; S Jemni Yacoub
Journal:  Transfus Med       Date:  2013-06-07       Impact factor: 2.019

6.  Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in south-western Germany.

Authors:  F F Wagner; D Kasulke; M Kerowgan; W A Flegel
Journal:  Infusionsther Transfusionsmed       Date:  1995-10

7.  RH diversity in Mali: characterization of a new haplotype RHD*DIVa/RHCE*ceTI(D2).

Authors:  Alhassane Ba; Sophie Beley; Jacques Chiaroni; Pascal Bailly; Monique Silvy
Journal:  Transfusion       Date:  2015-04-10       Impact factor: 3.157

8.  How I manage donors and patients with a weak D phenotype.

Authors:  Willy A Flegel
Journal:  Curr Opin Hematol       Date:  2006-11       Impact factor: 3.284

9.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

10.  International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012).

Authors:  J R Storry; L Castilho; G Daniels; W A Flegel; G Garratty; M de Haas; C Hyland; C Lomas-Francis; J M Moulds; N Nogues; M L Olsson; J Poole; M E Reid; P Rouger; E van der Schoot; M Scott; Y Tani; L-C Yu; S Wendel; C Westhoff; V Yahalom; T Zelinski
Journal:  Vox Sang       Date:  2013-12-27       Impact factor: 2.144

View more
  9 in total

1.  A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes.

Authors:  Willy A Flegel; Thierry Peyrard; Jacques Chiaroni; Christophe Tournamille; Déborah Jamet; France Pirenne
Journal:  Blood Transfus       Date:  2018-05-03       Impact factor: 3.443

2.  High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotype.

Authors:  Marcia Regina Dezan; Valéria B Oliveira; Çarolina Nunes Gomes; Fabio Luz; Antônio J Gallucci; Silvia L Bonifácio; Cecília Salete Alencar; Ester C Sabino; Alexandre C Pereira; Jose E Krieger; Vanderson Rocha; Alfredo Mendrone-Junior; Carla L Dinardo
Journal:  J Clin Lab Anal       Date:  2018-06-26       Impact factor: 2.352

3.  Transfusion support during childbirth for a woman with anti-U and the RHD*weak D type 4.0 allele.

Authors:  Q Yin; K Srivastava; D G Brust; W A Flegel
Journal:  Immunohematology       Date:  2021-03

4.  What constitutes the most cautious approach for a pregnant person with weak D type 4.0?

Authors:  Willy Albert Flegel; Melanie Bodnar; Gwen Clarke; Judith Hannon; Lani Lieberman
Journal:  CMAJ       Date:  2021-06-14       Impact factor: 8.262

5.  Proceed with care: the "uncommon" serologic weak D phenotypes.

Authors:  Willy Albert Flegel
Journal:  Blood Transfus       Date:  2021-07       Impact factor: 3.443

Review 6.  Genotyping in Sickle Cell Disease Patients: The French Strategy.

Authors:  Aline Floch; Christophe Tournamille; Btissam Chami; France Pirenne
Journal:  Transfus Med Hemother       Date:  2018-07-06       Impact factor: 3.747

7.  Implementation of Molecular RHD Typing at Two Blood Transfusion Institutes from Southeastern Europe.

Authors:  Gordana Guzijan; Snezana Jovanovic Srzentic; Natasa Pavlovic Jankovic; Iva Djilas; Marko Lilić
Journal:  Transfus Med Hemother       Date:  2019-02-15       Impact factor: 3.747

8.  It's time to phase out "serologic weak D phenotype" and resolve D types with RHD genotyping including weak D type 4.

Authors:  Willy A Flegel; Gregory A Denomme; John T Queenan; Susan T Johnson; Margaret A Keller; Connie M Westhoff; Louis M Katz; Meghan Delaney; Ralph R Vassallo; Clayton D Simon; S Gerald Sandler
Journal:  Transfusion       Date:  2020-03-12       Impact factor: 3.337

9.  High prevalence of serological weak D phenotype and preponderance of weak D type 4.0.1. genetic variant in a Nigerian population: implications for transfusion practice in a resource-limited setting.

Authors:  Dauda Usman Maryam; Isyaku Gwarzo Mukhtar; Aminu Abba Yusuf; Ahmed Ibrahim Salisu
Journal:  Hematol Transfus Cell Ther       Date:  2021-03-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.